Krishna Institute of Medical Sciences Ltd
Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.
- Market Cap ₹ 16,044 Cr.
- Current Price ₹ 2,005
- High / Low ₹ 2,357 / 1,453
- Stock P/E 47.5
- Book Value ₹ 227
- Dividend Yield 0.00 %
- ROCE 23.7 %
- ROE 21.3 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 55.4% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.5%
Cons
- Stock is trading at 8.85 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
- Debtor days have increased from 33.5 to 42.0 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|
512 | 567 | 664 | 918 | 1,123 | 1,330 | 1,651 | 2,198 | 2,440 | |
403 | 450 | 593 | 833 | 872 | 953 | 1,126 | 1,598 | 1,796 | |
Operating Profit | 109 | 118 | 71 | 85 | 251 | 377 | 524 | 599 | 645 |
OPM % | 21% | 21% | 11% | 9% | 22% | 28% | 32% | 27% | 26% |
5 | 3 | 37 | 6 | 5 | 9 | 27 | 52 | 14 | |
Interest | 37 | 32 | 88 | 49 | 44 | 37 | 22 | 37 | 36 |
Depreciation | 36 | 35 | 40 | 56 | 71 | 70 | 73 | 129 | 136 |
Profit before tax | 41 | 53 | -20 | -15 | 141 | 279 | 457 | 485 | 487 |
Tax % | 32% | 37% | -126% | -223% | 18% | 26% | 25% | 25% | |
28 | 33 | -46 | -49 | 115 | 205 | 344 | 366 | 363 | |
EPS in Rs | 3.78 | 4.55 | -6.61 | -6.40 | 16.00 | 25.93 | 41.57 | 42.03 | 42.23 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 27% |
3 Years: | 25% |
TTM: | 22% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 55% |
3 Years: | 41% |
TTM: | 8% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 33% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 22% |
3 Years: | 25% |
Last Year: | 21% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 70 | 72 | 50 | 74 | 74 | 78 | 80 | 80 | 80 |
Reserves | 193 | 255 | -209 | 466 | 523 | 786 | 1,307 | 1,590 | 1,733 |
256 | 280 | 753 | 336 | 369 | 316 | 257 | 678 | 956 | |
146 | 167 | 359 | 237 | 228 | 253 | 260 | 553 | 650 | |
Total Liabilities | 665 | 774 | 954 | 1,114 | 1,194 | 1,433 | 1,904 | 2,901 | 3,419 |
515 | 518 | 755 | 863 | 916 | 931 | 1,005 | 1,766 | 1,927 | |
CWIP | 2 | 64 | 0 | 0 | 2 | 9 | 21 | 477 | 638 |
Investments | 11 | 14 | 0 | 0 | 0 | 0 | 332 | 68 | 116 |
137 | 177 | 199 | 250 | 276 | 493 | 546 | 590 | 739 | |
Total Assets | 665 | 774 | 954 | 1,114 | 1,194 | 1,433 | 1,904 | 2,901 | 3,419 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|
95 | 82 | 106 | 134 | 202 | 356 | 324 | 432 | |
-41 | -100 | -64 | -110 | -125 | -354 | -412 | -484 | |
-65 | 24 | -39 | -27 | -44 | 10 | 61 | 88 | |
Net Cash Flow | -11 | 5 | 3 | -3 | 32 | 12 | -26 | 36 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|
Debtor Days | 47 | 59 | 59 | 49 | 43 | 30 | 28 | 42 |
Inventory Days | 36 | 43 | 46 | 47 | 44 | 30 | 37 | 33 |
Days Payable | 194 | 207 | 215 | 181 | 177 | 167 | 133 | 132 |
Cash Conversion Cycle | -111 | -105 | -110 | -85 | -91 | -106 | -67 | -58 |
Working Capital Days | 11 | 26 | -315 | -7 | -10 | -6 | 4 | 15 |
ROCE % | 15% | 11% | 5% | 20% | 29% | 34% | 24% |
Documents
Announcements
-
Compliance Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015.
15h - Compliance certificate U/r 40 (9) of (SEBI) LODR, 2015
- Explanation Under Regulation 30 Read With Schedule III Of SEBI LODR Regulations, 2015 Towards Receipt Of Demand Notice Issued By The Income Tax Department To Our Subsidiary Company. 18 Apr
- Compliance- Compliance Certificate U/R 7(3) For The Period Ended 31St March, 2024. 18 Apr
- Disclosure under regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015 16 Apr
-
Announcement Under Regulation 30 LODR
16 Apr - Regarding receipt of demand notice to a subsidiary under section 156 of the Income Tax Act, 1961.
Annual reports
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Oct 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
Regional Leadership
KIMS is one of the largest corporate healthcare groups in Andhra Pradesh (AP) and Telangana in terms of the number of patients treated and treatments offered. It provides multidisciplinary integrated healthcare services, with a focus on primary, secondary & tertiary care in tier 2-3 cities and primary, secondary, tertiary, and quaternary healthcare in tier 1 cities. [1]